A drugmaker has recalled over 20,000 bottles of icosapent ethyl (IPE), a generic version of the triglyceride -lowering medication known by the brand name Vascepa. Oxidation is causing the capsules to leak, which could reduce the drug’s effectiveness and lead to stomach issues, according to an enforcement report from the U.S. Food and Drug Administration (FDA).e60dc2a1-f33c-4a05-9b50-8e3e8e597629bf4b443e-b9eb-489f-bc2f-4005482cb334 Icosapent ethyl is a medication for high triglycerides (fats that circulate in the blood) that contains a highly purified form of omega-3 fatty acids derived from fish oil. Doctors may prescribe icosapent ethyl along with statins to lower the risk of heart attack, stroke, and other cardiovascular complications of heart disease and diabetes.e60dc2a1-f33c-4a05-9b50-8e3e8e59762983f250a7-5d10-4647-9427-eeee85e5f1e9 New Jersey–based Zydus Pharmaceuticals issued a voluntary recall of the following lots of 120-count icosapent ethyl 1-gram capsules : Lot # S2520304, Exp 2/28/2027 Lot # S2520333, Exp 2/28/2027 Lot # S2540186, Exp 4/30/2027 The enforcement report lists the recall as a Class 2 event, which means use of the recalled product can “cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”e60dc2a1-f33c-4a05-9b50-8e3e8e59762950d798af-0ab2-403f-b0f0-73fcb30827c4 There were no specific instructions in the enforcement report about what to do with the recalled icosapent ethyl capsules. For Class 2 recalls, the FDA says stopping your medicine could be more harmful than continuing to take recalled products.e60dc2a1-f33c-4a05-9b50-8e3e8e5976290f597664-a330-42dd-8c64-1bb99850fe76 Contact your pharmacy if you have any concerns or want replacement medication.
Read the full article here
Leave a comment
